fbpx
Monday, July 4, 2022

Global Intestinal Pseudo Obstruction Treatment Market Report 2022-2027 Featuring Pfizer, Cipla, GlaxoSmithKline, Teva., Eli Lilly and Co, Novartis, J&J, Dr. Reddy’s Lab, F. Hoffmann-La Roche, Lupin

Must read

DUBLIN, May 20, 2022 /PRNewswire/ — The “Global Intestinal Pseudo Obstruction Treatment Market, By Condition (Acute v/s Chronic), By Diagnosis (Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Others), By Treatment, By End User, By Region, Competitional Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

Global intestinal pseudo obstruction treatment market is anticipated to grow at a formidable rate with growth attributed to the increasing instances of complexities related to pseudo obstruction, a rare condition where muscle impairment causes disruption in the gastro-intestinal muscle contraction when neurons are not able to function properly.

If untreated, the intestinal pseudo obstruction could cause abdominal swelling, pain, nausea, constipation, or diarrhea. In extreme conditions, people can lose their appetite or may find difficulty in nutrient absorption, which can lead to malnutrition. Rapidly increasing incidences of various stomach ailments, indigestion, and other diseases are expected to drive the growth of the global intestinal pseudo obstruction treatment market.

The risk of pseudo obstruction increases with aging due to neural degeneration or muscle abnormalities, thus increasing geriatric population across the globe is contributing to the growth of intestinal pseudo obstruction treatment market. Increasing advancements in technology and rising research initiatives towards products and treatment methodologies for intestinal pseudo obstruction treatment are some of the factors expected to propel the growth of pseudo obstruction treatment market in the next five years.

New innovations in gastro intestinal imaging and manometry of the organ tract are supporting the growth of the global intestinal pseudo obstruction treatment market.

Furthermore, rising healthcare expenditure and growing initiatives by public and private organizations to enhance awareness about diseases are supporting the growth of the global intestinal pseudo obstruction treatment market. However, high cost of the medical treatment and its possible side-effects are expected to hinder the growth of the global intestinal pseudo obstruction treatment market during the forecast period.



The global intestinal pseudo obstruction treatment market segmentation is based on condition, diagnosis, treatment, end user, regional distribution, and competitive Landscape. Based on region, North America is expected to dominate the global pseudo obstruction treatment market owing to rising awareness about health-related problems and presence of well-developed healthcare in the region.



Major players dominating the global intestinal pseudo obstruction treatment market include Pfizer, Inc., Cipla Inc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Novartis AG, Johnson & Johnson, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Lupin Limited, among others.

Objective of the Study:

  • To analyze the historical growth in the market size of global intestinal pseudo obstruction treatment market from 2017 to 2021
  • To estimate and forecast the market size of global intestinal pseudo obstruction treatment market from 2022E to 2027F and growth rate until 2027F
  • To classify and forecast global intestinal pseudo obstruction treatment market based on condition, treatment, diagnosis, end user, region, and competitive Landscape
  • To identify dominant region or segment in the global intestinal pseudo obstruction treatment market
  • To identify drivers and challenges for global intestinal pseudo obstruction treatment market
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc, in global intestinal pseudo obstruction treatment market
  • To identify and analyze the profile of leading players operating in global intestinal pseudo obstruction treatment market
  • To identify key sustainable strategies adopted by market players in global intestinal pseudo obstruction treatment market

Key Topics Covered:



1. Service Overview



2. Research Methodology



3. Executive Summary



4. Impact of COVID-19 on Global Intestinal Pseudo Obstruction Treatment Market



5. Voice of Customer

5.1. Factors Contributing to Intestinal Pseudo Obstruction

5.2. Commonly Observed Symptoms of Intestinal Pseudo Obstruction

5.3. Intestinal Pseudo Obstruction Prevalence, By Age Group

5.4. Intestinal Pseudo Obstruction Prevalence, By Gender

5.5. Commonly Used Diagnostic Procedures for Intestinal Pseudo Obstruction

5.6. Preference for Intestinal Pseudo Obstruction Treatment, By Type

5.7. Brand Awareness



6. Global Intestinal Pseudo Obstruction Treatment Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Condition (Acute v/s Chronic)

6.2.2. By Diagnosis (Physical Examination, Biopsy, Blood Test, Gastric Emptying Tests, Imaging Tests, Others)

6.2.3. By Treatment (Medication, Surgery, Diet, Others)

6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

6.2.5. By Company (2021)

6.2.6. By Region

6.3. Market Map



7. North America Intestinal Pseudo Obstruction Treatment Market Outlook

7.1. Market Size & Forecast

7.2. Market Share & Forecast

7.3. North America: Country Analysis

7.3.1. United States Intestinal Pseudo Obstruction Treatment Market Outlook

7.3.2. Mexico Intestinal Pseudo Obstruction Treatment Market Outlook

7.3.3. Canada Intestinal Pseudo Obstruction Treatment Market Outlook



8. Europe Intestinal Pseudo Obstruction Treatment Market Outlook

8.1. Market Size & Forecast

8.2. Market Share & Forecast

8.3. Europe: Country Analysis

8.3.1. France Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.2. Germany Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.3. United Kingdom Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.4. Italy Intestinal Pseudo Obstruction Treatment Market Outlook

8.3.5. Spain Intestinal Pseudo Obstruction Treatment Market Outlook



9. Asia-Pacific Intestinal Pseudo Obstruction Treatment Market Outlook

9.1. Market Size & Forecast

9.2. Market Share & Forecast

9.3. Asia-Pacific: Country Analysis

9.3.1. China Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.2. India Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.3. South Korea Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.4. Japan Intestinal Pseudo Obstruction Treatment Market Outlook

9.3.5. Australia Intestinal Pseudo Obstruction Treatment Market Outlook



10. South America Intestinal Pseudo Obstruction Treatment Market Outlook

10.1. Market Size & Forecast

10.2. Market Share & Forecast

10.3. South America: Country Analysis

10.3.1. Brazil Intestinal Pseudo Obstruction Treatment Market Outlook

10.3.2. Argentina Intestinal Pseudo Obstruction Treatment Market Outlook

10.3.3. Colombia Intestinal Pseudo Obstruction Treatment Market Outlook



11. Middle East and Africa Intestinal Pseudo Obstruction Treatment Market Outlook

11.1. Market Size & Forecast

11.2. Market Share & Forecast

11.3. Middle East and Africa: Country Analysis

11.3.1. South Africa Intestinal Pseudo Obstruction Treatment Market Outlook

11.3.2. Saudi Arabia Intestinal Pseudo Obstruction Treatment Market Outlook

11.3.3. UAE Intestinal Pseudo Obstruction Treatment Market Outlook



12. Market Dynamics

12.1. Drivers

12.2. Challenges



13. Market Trends & Developments



14. Competitive Landscape

14.1. Pfizer, Inc.

14.2. Cipla Inc.

14.3. GlaxoSmithKline Plc.

14.4. Teva Pharmaceutical Industries Ltd.

14.5. Eli Lilly and Company

14.6. Novartis AG

14.7. Johnson & Johnson

14.8. Dr. Reddy’s Laboratories Ltd.

14.9. F. Hoffmann-La Roche AG

14.10. Lupin Limited



15. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/pwdhet

Media Contact:

Research and Markets 

Laura Wood, Senior Manager 

press@researchandmarkets.com 

For E.S.T Office Hours Call +1-917-300-0470 

For U.S./CAN Toll Free Call +1-800-526-8630 

For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 

Fax (outside U.S.): +353-1-481-1716




Cision View original content:https://www.prnewswire.com/news-releases/global-intestinal-pseudo-obstruction-treatment-market-report-2022-2027-featuring-pfizer-cipla-glaxosmithkline-teva-eli-lilly-and-co-novartis-jj-dr-reddys-lab-f-hoffmann-la-roche-lupin-301551941.html

SOURCE Research and Markets

spot_img

More articles

Latest article